“Increased Adoption of NGS for Early Diagnosis”
The adoption of next-generation sequencing (NGS) technologies, such as Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES), is increasingly focused on the early diagnosis of rare genetic diseases. These technologies enable precise identification of genetic mutations at a much earlier stage than traditional methods, allowing for timely diagnosis of conditions that would otherwise be difficult to detect. This trend is leading to more accurate and personalized treatment plans for patients, improving clinical outcomes by targeting the specific genetic causes of diseases. As NGS technologies continue to advance, healthcare providers are integrating them more widely into diagnostic workflows, aiming to enhance the accuracy and efficiency of diagnosing rare diseases from an early stage.
